Mon, November 21, 2022

Catherine Schulte Maintained (TWST) at Buy with Decreased Target to $33 on, Nov 21st, 2022

Catherine Schulte of Baird, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Decreased Target from $56 to $33 on, Nov 21st, 2022.

Catherine, nor any peers, have made any analyst calls on TWST in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30